Cargando…

COVID-19 infection in NMO/SD patients: a French survey

Detalles Bibliográficos
Autores principales:	Zeidan, Sinéad, Maillart, Elisabeth, Louapre, Céline, Roux, Thomas, Lubetzki, Catherine, Papeix, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486806/ https://www.ncbi.nlm.nih.gov/pubmed/32920657 http://dx.doi.org/10.1007/s00415-020-10112-1

Ejemplares similares

Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Wernicke’s Encephalopathy Precipitated by Area Postrema Syndrome of NMO-SD
por: Anuradha, Mahto, et al.
Publicado: (2023)

Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center
por: Roux, Thomas, et al.
Publicado: (2017)

Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
por: Louapre, C., et al.
Publicado: (2020)

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
por: Zeka, Bleranda, et al.
Publicado: (2016)

Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination
por: Jeantin, Lina, et al.
Publicado: (2022)

Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role?
por: Mantero, Vittorio, et al.
Publicado: (2020)

Multiple sclerosis in 2020: un bon cru
por: Maillart, Elisabeth, et al.
Publicado: (2021)

Finding NMO
por: Daneman, Richard
Publicado: (2016)

Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives
por: Ceglie, Giulia, et al.
Publicado: (2020)

Anti-CD20 et sévérité de la COVID-19 chez les patients SEP : un impact différent chez les SEP rémittents et progressifs, dans la cohorte COVISEP
por: Januel, Édouard, et al.
Publicado: (2023)

Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome
por: Maillart, Elisabeth, et al.
Publicado: (2017)

Mitoxantrone in NMO Spectrum Disorder in a Large Multicenter Cohort in French Caribbean
por: Chaumont, Hugo, et al.
Publicado: (2023)

Evaluation of an integrated multidisciplinary approach in multiple sclerosis care: A prospective, randomized, controlled study
por: Papeix, Caroline, et al.
Publicado: (2015)

Therapy of NMO spectrum disorders
por: Biswas, Atanu, et al.
Publicado: (2015)

Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort
por: Papeix, Caroline, et al.
Publicado: (2016)

Clinical impact of COVID-19 on a French population of spondyloarthritis patients
por: Roux, Christian Hubert, et al.
Publicado: (2020)

Neurodegeneration in MS and NMO: The Eye and the Blood
por: Petzold, Axel, et al.
Publicado: (2011)

Neuromyelitis optica (NMO) and autoimmune thyroiditis
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2015)

Improvement of tooth-bleaching survey and its validation in French
por: Delrieu, Julien, et al.
Publicado: (2022)

COVID-19 vaccine acceptance among haemodialysis patients: a French survey
por: Andrian, Titus, et al.
Publicado: (2021)

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis
por: Bodini, Benedetta, et al.
Publicado: (2016)

Saksenaea vasiformis Infection, French Guiana
por: Blanchet, Denis, et al.
Publicado: (2008)

SD-OCT based management of traumatic sub-macular hemorrhage-Our experience
por: Sampangi, Raju, et al.
Publicado: (2013)

Autoimmune thyroiditis associated with neuromyelitis optica (NMO)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2015)

Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease: CHANCE(NMO) Study
por: Hümmert, Martin W., et al.
Publicado: (2022)

Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis
por: Sterlin, Delphine, et al.
Publicado: (2021)

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)

Overview of patients’ cohorts in the French National rare disease registry
por: Pichon, Thibaut, et al.
Publicado: (2023)

Adequacy between practice and European guidelines on hyponatremia: a survey among French nephrologists
por: Martzloff, Jonas, et al.
Publicado: (2022)

CO7.1 - Anti-CD20 et sévérité de la COVID-19 chez les patients vivants avec une sclérose en plaques dans la cohorte COVISEP: un impact différent selon la forme progressive ou récurrente-rémittente de la sclérose en plaques
por: Januel, E., et al.
Publicado: (2023)

National survey on genetic test prescription in French adult nephrologists: a call for simplification and education
por: Doreille, Alice, et al.
Publicado: (2022)

Rift Valley Fever Virus Infection among French Troops in Chad
por: Durand, Jean Paul, et al.
Publicado: (2003)

Malaria Outbreak in Troops Returning from French Guiana
por: Verret, Catherine, et al.
Publicado: (2006)

Lung transplantation for COVID-19-associated acute respiratory distress syndrome: The first French patient
por: Glorion, M., et al.
Publicado: (2021)

Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?
por: Kinoshita, Makoto, et al.
Publicado: (2012)

NMO-IgG: A Specific Biomarker for Neuromyelitis Optica
por: Weinshenker, Brian G., et al.
Publicado: (2006)

Wallenda-Nmo Axis Regulates Growth via Hippo Signaling
por: Wang, Xianping, et al.
Publicado: (2021)

Evaluation of French-language internet sites dealing with multiple sclerosis
por: Guéguen, Antoine, et al.
Publicado: (2016)

Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey
por: Barrière, J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7utl8ou4lm25ta14jc0fbgfmrt